Researchers at the University of Pennsylvania analyzed health records from roughly 12,004 adults with Type 2 diabetes who started taking GLP-1 medications between 2019 and 2024, comparing them with tens of thousands of other patients using two other diabetes drugs, SGLT-2 inhibitors and DPP-4 inhibitors
According to this review, GLP-1 medication seemed most beneficial to the following groups: those higher starting weight and BMI those without diabetes younger females people who used GLP-1s for longer durations A study funded by WW but carried out by independent research teams found that after 3 months, people following a WW program lost an average of 3.8 kg compared to those on a do it yourself weight loss plan, who lost around 1.8 kg

Efectos gastrointestinales principales: Nuseas : el efecto secundario ms comn, usualmente transitorio, con frecuencia variable segn la dosis Diarrea : puede variar en frecuencia e intensidad Vmitos : ms frecuente con dosis ms altas Estreimiento : puede alternarse con episodios de diarrea Dolor abdominal : generalmente leve y autolimitado Dispepsia e indigestin : sensacin de malestar digestivo Distensin abdominal : sensacin de plenitud o hinchazn Otros efectos adversos reportados: Disminucin del apetito: efecto teraputico deseado que puede ser excesivo Reacciones en el sitio de inyeccin: enrojecimiento, picazn o molestia leve Hipoglucemia: riesgo aumentado cuando se combina con sulfonilureas o insulina
Perfect your injection technique Technique errors cause or worsen the majority of injection site reactions
See our Best Tirzepatide Online ranking, Best Semaglutide Online, or the cross-medication Best GLP-1 Programs comparison.
Reported side effects from topical application are generally mild